0001140361-25-005827.txt : 20250225 0001140361-25-005827.hdr.sgml : 20250225 20250225150503 ACCESSION NUMBER: 0001140361-25-005827 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250225 DATE AS OF CHANGE: 20250225 EFFECTIVENESS DATE: 20250225 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Grace Therapeutics, Inc. CENTRAL INDEX KEY: 0001444192 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-539175 FILM NUMBER: 25662441 BUSINESS ADDRESS: STREET 1: 103 CARNEGIE CENTER STREET 2: SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-322-1602 MAIL ADDRESS: STREET 1: 103 CARNEGIE CENTER STREET 2: SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: Acasti Pharma Inc. DATE OF NAME CHANGE: 20080828 D 1 primary_doc.xml X0708 D LIVE 0001444192 Grace Therapeutics, Inc. 103 Carnegie Center Suite 300 Princeton NJ NEW JERSEY 08540 609-322-1602 DELAWARE None Acasti Pharma Inc. Corporation true Prashant Kohli 103 Carnegie Center Suite 300 Princeton NJ NEW JERSEY 08540 Director Executive Officer Chief Executive Officer Vimal Kavuru 103 Carnegie Center Suite 300 Princeton NJ NEW JERSEY 08540 Director Robert J. DelAversano 103 Carnegie Center Suite 300 Princeton NJ NEW JERSEY 08540 Executive Officer Vice President, Finance, Principal Financial Officer and Principal Accounting Officer A. Brian Davis 103 Carnegie Center Suite 300 Princeton NJ NEW JERSEY 08540 Director S. George Kottayil 103 Carnegie Center Suite 300 Princeton NJ NEW JERSEY 08540 Director Edward Neugeboren 103 Carnegie Center Suite 300 Princeton NJ NEW JERSEY 08540 Director Dr. R. Loch Macdonald 103 Carnegie Center Suite 300 Princeton NJ NEW JERSEY 08540 Executive Officer Chief Medical Officer Carrie D'Andrea 103 Carnegie Center Suite 300 Princeton NJ NEW JERSEY 08540 Executive Officer VP Clinical Operations Amresh Kumar 103 Carnegie Center Suite 300 Princeton NJ NEW JERSEY 08540 Executive Officer VP of Program Management Biotechnology No Revenues 06b false 2025-02-10 false true true true false 1 TD Securities (USA) LLC 18476 None None 1 Vanderbilt Avenue New York NY NEW YORK 10017 CT CONNECTICUT DE DELAWARE MD MARYLAND NY NEW YORK NC NORTH CAROLINA OR OREGON SD SOUTH DAKOTA TX TEXAS 30000203 14999985 15000218 The offering amount reflects the aggregate purchase price received and exercise price due to the Company assuming cash exercise of all warrants issued to the accredited investors under Rule 506(b). false 14 1530011 0 Placement agent received a cash fee of $764,999 upon closing and is entitled to receive cash fees of up to $765,012 in connection with exercises of warrants purchased in the private placement. 0 false Grace Therapeutics, Inc. /s/ Prashant Kohli Prashant Kohli CEO 2025-02-25